Vitamin D3 at 50x AI Attenuates the Decline in Paw Grip Endurance, but Not Disease Outcomes, in the G93A Mouse Model of ALS, and Is Toxic in Females

Gianforcaro, Alexandro; Solomon, Jesse A.; Hamadeh, Mazen J
February 2013
PLoS ONE;Feb2013, Vol. 8 Issue 2, p1
Academic Journal
Background: We previously demonstrated that dietary vitamin D3 at 10x the adequate intake (AI) attenuates the decline in functional capacity in the G93A mouse model of ALS. We hypothesized that higher doses would elicit more robust changes in functional and disease outcomes. Objective: To determine the effects of dietary vitamin D3 at 50xAI on functional outcomes (motor performance, paw grip endurance) and disease severity (clinical score), as well as disease onset, disease progression and lifespan in the transgenic G93A mouse model of ALS. Methods: Starting at age 25 d, 100 G93A mice (55 M, 45 F) were provided ad libitum with either an adequate (AI; 1 IU D3/g feed) or high (HiD; 50 IU D3/g feed) vitamin D3 diet. Results: HiD females consumed 9% less food corrected for body weight vs. AI females (P = 0.010). HiD mice had a 12% greater paw grip endurance over time between age 60–141 d (P = 0.015), and a 37% greater score during disease progression (P = 0.042) vs. AI mice. Although HiD females had a non-significant 31% greater CS prior to disease onset vs. AI females, they exhibited a significant 20% greater paw grip endurance AUC (P = 0.020) when corrected for clinical score. Conclusion: Dietary D3 supplementation at 50x the adequate intake attenuated the decline in paw grip endurance, but did not influence age at disease onset, hindlimb paralysis or endpoint in the transgenic G93A mouse model of ALS. Furthermore, females may have reached the threshold for vitamin D3 toxicity as evidence by reduced food intake and greater disease severity prior to disease onset.


Related Articles

  • Antagonism of T-type calcium channels inhibits high-fat diet–induced weight gain in mice. Uebele, Victor N.; Gotter, Anthony L.; Nuss, Cindy E.; Kraus, Richard L.; Doran, Scott M.; Garson, Susan L.; Reiss, Duane R.; Yuxing Li; Barrow, James C.; Reger, Thomas S.; Zhi-Qiang Yang; Ballard, Jeanine E.; Cuyue Tang; Metzger, Joseph M.; Sheng-Ping Wang,4 Kenneth S. Koblan,4 and John J. Renger1 // Journal of Clinical Investigation;Jun2009, Vol. 119 Issue 6, p1659 

    The epidemics of obesity and metabolic disorders have well-recognized health and economic burdens. Pharmacologic treatments for these diseases remain unsatisfactory with respect to both efficacy and side-effect profiles. Here, we have identified a potential central role for T-type calcium...

  • Diet-induced obesity affects maternal behavior in mice. Yamamoto, Atsuko // Japanese Journal of Veterinary Research;Aug2011, Vol. 59 Issue 2/3, p123 

    The article analyses how maternal behavior has been affected through obesity and also describes the mechanism related to obesity induced effects. It mentions that the study was performed on a female C57BL/6J mice by providing high fat diet (HFD) for 16 weeks. The study reveals that the body...

  • Treatment of db/db diabetic mice with triptolide: a novel therapy for diabetic nephropathy. Gao, Qing; Shen, Wenwen; Qin, Weisong; Zheng, Chunxia; Zhang, Mingchao; Zeng, Caihong; Wang, Shengyu; Wang, Jianping; Zhu, Xiaodong; Liu, Zhihong // Nephrology Dialysis Transplantation;Nov2010, Vol. 25 Issue 11, p3539 

    Background. Current research on the progression of diabetic nephropathy (DN) suggests many important factors; metabolic disturbance, haemodynamic abnormity, chronic inflammation, oxidative stress, innate immune system activation and podocyte lesion. Triptolide, which is active diterpene purified...

  • Effect of FTY720 on Some Physiological Indexes of Non-Obese Diabetic (NOD) Mice. Xiaoqiang Chen; Sudan Ye; Shikang Zhang; Jianrong Li; Hongying Zhu; Gaoli Zheng; Yin Lu; Haitong Wan // International Journal of Molecular Sciences;May2012, Vol. 13 Issue 5, p6129 

    The studies were performed to investigate the physiological characteristics of non-obese diabetic (NOD) mice treated with FTY720. At the age of 12 weeks, each mouse was fed with FTY720 or physiological saline once a day for 10 weeks running, and their blood glucose, weight, anti-GAD antibody and...

  • Potato protease inhibitors inhibit food intake and increase circulating cholecystokinin levels by a trypsin-dependent mechanism. Komarnytsky, S.; Cook, A.; Raskin, I. // International Journal of Obesity;Feb2011, Vol. 35 Issue 2, p236 

    Objective:To investigate the mechanisms underlying the satiety-promoting effects of a novel protease inhibitor concentrate derived from potato (PPIC).Methods:The acute and prolonged effects of oral PPIC administration (100 mg kg−1 per day) on food intake, body weight and gastric emptying...

  • Increased motivation to eat in opiate-withdrawn mice. Rouibi, Khalil; Contarino, Angelo // Psychopharmacology;Jun2012, Vol. 221 Issue 4, p675 

    Rationale: In drug-dependent individuals, the primary excessive motivation is for drugs. Studies also indicate altered interest for 'natural' rewarding activities associated with motivational disorders that may be relevant to drug dependence. However, to date, the impact of drug dependence and...

  • AgRP neurons: a switch between peripheral carbohydrate and lipid utilization. Varela, Luis; Horvath, Tamas L // EMBO Journal;11/14/2012, Vol. 31 Issue 22, p4252 

    No abstract available.

  • Intracerebroventricular administration of melanotan II increases insulin sensitivity of glucose disposal in mice. Heijboer, A. C.; van den Hoek, A. M.; Pijl, H.; Voshol, P. J.; Havekes, L. M.; Romijn, J. A.; Corssmit, E. P. M. // Diabetologia;Aug2005, Vol. 48 Issue 8, p1621 

    Aims/hypothesis: The present study was conducted to evaluate the effects of central administration of melanotan II (MTII), a melanocortin-3/4 receptor agonist, on hepatic and whole-body insulin sensitivity, independent of food intake and body weight. Methods: Over a period of 24 h, 225 ng of...

  • Adipocyte-Specific Circadian Control of Appetite and Feeding Behavior. Resnick, Helaine E. // Diabetes;Apr2013, Vol. 62 Issue 4, p1352 

    The article discusses research being done on the impact of Arntl deletion from adipocytes on weight and food intake in mice. It references a study by Georgios Paschos and colleagues published in a 2012 issue of "Nature Medicine." Results of the study showed that there was marked disruption of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics